Gehauchte Diagnosen? Zum Potenzial von Atemkondensatuntersuchungen

C. Gessner; S. Hammerschmidt; H. Kuhn; H. Wirtz

doi:10.1055/s-2004-818411

Pneumologie, Table of Contents

Pneumologie 2004; 58(4): 230-237
DOI: 10.1055/s-2004-818411

Übersicht

Gehauchte Diagnosen? Zum Potenzial von Atemkondensatuntersuchungen

Expired Diagnosis?-The Potential of Exhaled Breath AnalysisC. Gessner¹ , S. Hammerschmidt¹ , H. Kuhn¹ , H. Wirtz¹

¹Medizinische Klinik und Poliklinik I, Universitätsklinikum Leipzig (Direktor: Prof. Dr. med. J. Schauer)

Herrn Prof. Dr. med. Joachim Schauer zum 65. Geburtstag gewidmet.

Abstract

Full Text

References

Literatur

1 Kharitonov S A, Barnes P J. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001; 163 (7) 1693-1722
2 Ricciardolo F L. Multiple roles of nitric oxide in the airways. Thorax. 2003; 58 (2) 175-182
3 Paredi P, Kharitonov S A, Barnes P J. Analysis of expired air for oxidation products. Am J Respir Crit Care Med. 2002; 166 (12 Pt 2) S31-37
4 Silkoff P E, Martin D, Pak J. et al . Exhaled nitric oxide correlated with induced sputum findings in COPD. Chest. 2001; 119 (4) 1049-1055
5 Blease K, Kunkel S L, Hogaboam C M. Acute inhibition of nitric oxide exacerbates airway hyperresponsiveness, eosinophilia and C-C chemokine generation in a murine model of fungal asthma. Inflamm Res. 2000; 49 (6) 297-304
6 Feder L S, Stelts D, Chapman R W. et al . Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol. 1997; 17 (4) 436-442
7 Strunk R C, Szefler S J, Phillips B R. et al . Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol. 2003; 112 (5) 883-892
8 Nogami H, Shoji S, Nishima S. Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients. J Asthma. 2003; 40 (6) 653-659
9 Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 1999; 160 (6) 2104-2117
10 Fairchild C I, Stampfer J F. Particle concentration in exhaled breath. Am Ind Hyg Assoc J. 1987; 48 (11) 948-949
11 Jorres R A, Holz O. [Non-invasive inflammation monitoring]. Pneumologie. 2001; 55 (9) 406-408
12 Becher G, Beck E, Rothe M. et al . Sammlung von nichtgasförmigen Bestandteilen des Ausatemluft durch Ausfrieren. Medizintechnik. 1997; 117 89-95
13 Griese M, Noss J, Bredow C von. Protein pattern of exhaled breath condensate and saliva. Proteomics. 2002; 2 (6) 690-696
14 Effros R M, Hoagland K W, Bosbous M. et al . Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med. 2002; 165 (5) 663-669
15 Gessner C, Kuhn H, Seyfarth H J. et al . Factors influencing breath condensate volume. Pneumologie. 2001; 55 (9) 414-419
16 Vass G, Huszar E, Barat E. et al . Comparison of nasal and oral inhalation during exhaled breath condensate collection. Am J Respir Crit Care Med. 2003; 167 (6) 850-855
17 Huszar E, Vass G, Vizi E. et al . Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J. 2002; 20 (6) 1393-1398
18 Begin R, Drapeau G, Boileau R. et al . Enzyme activities of lung lavage in asbestosis. Clin Biochem. 1986; 19 (4) 240-243
19 Rao S. Amylase in bronchial washings as an aid to early diagnosis of bronchogenic carcinoma. J Assoc Physicians India. 1995; 43 (6) 400
20 Kietzmann D, Kahl R, Muller M. et al . Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med. 1993; 19 (2) 78-81
21 Corradi M, Rubinstein I, Andreoli R. et al . Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167 (10) 1380-1386
22 Corradi M, Folesani G, Andreoli R. et al . Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med. 2003; 167 (3) 395-399
23 Montuschi P, Ragazzoni E, Valente S. et al . Ciabattoni. Validation of leukotriene B4 measurements in exhaled breath condensate. Inflamm Res. 2003; 52 (2) 69-73
24 Gessner C, Hammerschmidt S, Kuhn H. et al . Exhaled breath condensate acidification in acute lung injury. Respir Med. 2003; 97 (11) 1188-1194
25 Montuschi P, Ragazzoni E, Valente S. et al . Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. Inflamm Res. 2003; 52 (12) 502-507
26 Bucchioni E, Kharitonov S A, Allegra L. et al . High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med. 2003; 97 (12) 1299-1302
27 Carpagnano G E, Resta O, Foschino-Barbaro M P. et al . Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. Int J Biol Markers. 2002; 17 (2) 141-145
28 Carpagnano G E, Barnes P J, Geddes D M. et al . Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med. 2003; 167 (8) 1109-1112
29 Carpagnano G E, Kharitonov S A, Foschino-Barbaro M P. et al . Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J. 2003; 21 (4) 589-593
30 Shahid S K, Kharitonov S A, Wilson N M. et al . Increased interleukin-4 and decreased interferon-γ in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med. 2002; 165 (9) 1290-1293
31 Scheideler L, Manke H G, Schwulera U. et al . Detection of nonvolatile macromolecules in breath. A possible diagnostic tool?. Am Rev Respir Dis. 1993; 148 (3) 778-784
32 Effros R M, Biller J, Foss B. et al . A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med. 2003; 168 (12) 1500-1505
33 Gessner C, Hammerschmidt S, Kuhn H. et al . Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury. Chest. 2003; 124 (3) 1046-1052
34 Conner G E, Salathe M, Forteza R. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am J Respir Crit Care Med. 2002; 166 (12 Pt 2) S57-61
35 Horvath I, MacNee W, Kelly F J. et al . “Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. Eur Respir J. 2001; 18 (2) 420-430
36 Schleiss M B, Holz O, Behnke M. et al . The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J. 2000; 16 (6) 1115-1118
37 Beurden W J van, Dekhuijzen P N, Harff G A. et al . Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration. 2002; 69 (3) 211-216
38 Lehmann C, Rothe M, Becher B. A new method for rapid measurement of hydrogen peroxide in exhaled breath condensate. Am J Respir Crit Care Med. 2002; 165 53 (Abstract)
39 Dohlman A W, Black H R, Royall J A. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis. 1993; 148 (4 Pt 1) 955-960
40 Antczak A, Nowak D, Shariati B. et al . Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J. 1997; 10 (6) 1235-1241
41 Antczak A, Kurmanowska Z, Kasielski M. et al . Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respir Med. 2000; 94 (5) 416-421
42 Horvath I, Donnelly L E, Kiss A. et al . Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med. 1998; 158 (4) 1042-1046
43 Nowak D, Antczak A, Krol M. et al . Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur Respir J. 1996; 9 (4) 652-657
44 Dekhuijzen P N, Aben K K, Dekker I. et al . Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996; 154 (3 Pt 1) 813-816
45 Nowak D, Kasielski M, Pietras T. et al . Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD. Monaldi Arch Chest Dis. 1998; 53 (3) 268-273
46 Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med. 2001; 95 (6) 448-456
47 De Benedetto F, Aceto A, Dragani B. et al . Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch Chest Dis. 2000; 55 (3) 185-188
48 Loukides S, Horvath I, Wodehouse T. et al . Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med. 1998; 158 (3) 991-994
49 Loukides S, Bouros D, Papatheodorou G. et al . Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest. 2002; 121 (1) 81-87
50 Worlitzsch D, Herberth G, Ulrich M. et al . Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J. 1998; 11 (2) 377-383
51 Jobsis Q, Raatgeep H C, Schellekens S L. et al . Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J. 2000; 16 (1) 95-100
52 Baldwin S R, Simon R H, Grum C M. et al . Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet. 1986; 1 (8471) 11-14
53 Heard S O, Longtine K, Toth I. et al . The influence of liposome-encapsulated prostaglandin E1 on hydrogen peroxide concentrations in the exhaled breath of patients with the acute respiratory distress syndrome. Anesth Analg. 1999; 89 (2) 353-357
54 Nowak D, Kasielski M, Antczak A. et al . Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med. 1999; 93 (6) 389-396
55 Ferreira I M, Hazari M S, Gutierrez C. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit Care Med. 2001; 164 (6) 1012-1015
56 Beurden W J van, Harff G A, Dekhuijzen P N. et al . An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med. 2002; 96 (3) 197-203
57 Zappacosta B, Persichilli S, Mormile F. et al . A fast chemiluminescent method for H(2)O(2) measurement in exhaled breath condensate. Clin Chim Acta. 2001; 310 (2) 187-191
58 Ho L P, Innes J A, Greening A P. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax. 1998; 53 (8) 680-684
59 Kostikas K, Papatheodorou G, Ganas K. et al . pH in Expired Breath Condensate of Patients with Inflammatory Airway Diseases. Am J Respir Crit Care Med. 2002; 165 (10) 1364-1370
60 Corradi M, Pesci A, Casana R. et al . Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide. 2003; 8 (1) 26-30
61 Cunningham S, McColm J R, Ho L P. et al . Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J. 2000; 15 (5) 955-957
62 Formanek W, Inci D, Lauener R P. et al . Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J. 2002; 19 (3) 487-491
63 Kharitonov S A, Donnelly L E, Montuschi P. et al . Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax. 2002; 57 (10) 889-896
64 Hunt J, Byrns R E, Ignarro L J. et al . Condensed expirate nitrite as a home marker for acute asthma [letter]. Lancet. 1995; 346 (8984) 1235-1236
65 Ganas K, Loukides S, Papatheodorou G. et al . Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med. 2001; 95 (8) 649-654
66 Hanazawa T, Kharitonov S A, Barnes P J. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med. 2000; 162 (4 Pt 1) 1273-1276
67 Balint B, Kharitonov S A, Hanazawa T. et al . Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur Respir J. 2001; 17 (6) 1201-1207
68 Rothe M, Becher G, Kragl U. et al . Bestimmung von Tyrosin und Nitrotyrosin im Atemkondensat von CF-Patienten. Pneumologie. 2003; 57 S52 (Abstract)
69 Corradi M, Montuschi P, Donnelly L E. et al . Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med. 2001; 163 (4) 854-858
70 Driver A G, Kukoly C A, Ali S. et al . Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis. 1993; 148 (1) 91-97
71 Mann J S, Holgate S T, Renwick A G. et al . Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol. 1986; 61 (5) 1667-1676
72 Vizi E, Huszar E, Csoma Z. et al . Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol. 2002; 109 (3) 446-448
73 Antczak A, Montuschi P, Kharitonov S. et al . Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med. 2002; 166 (3) 301-306
74 Montuschi P, Kharitonov S A, Ciabattoni G. et al . Exhaled leukotrienes and prostaglandins in COPD. Thorax. 2003; 58 (7) 585-588
75 Reinhold P, Becher G, Rothe M. Evaluation of the measurement of leukotriene B4 concentrations in exhaled condensate as a noninvasive method for assessing mediators of inflammation in the lungs of calves. Am J Vet Res. 2000; 61 (7) 742-749
76 Csoma Z, Kharitonov S A, Balint B. et al . Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2002; 166 (10) 1345-1349
77 Neubauer B, Struck N, Mutzbauer T S. et al . Leukotriene-B4 concentrations in exhaled breath condensate and lung function after thirty minutes of breathing technically dried compressed air. Int Marit Health. 2002; 53 (1 - 4) 93-101
78 Montuschi P, Barnes P J. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol. 2002; 109 (4) 615-620
79 Becher G, Winsel K, Beck E. et al . Leukotriene B4 in breathing condensate of patients with bronchopulmonary diseases and of normal patients. Appl Cardiopulmon Pathophysiol. 1995; 5 215-219
80 Baraldi E, Carraio S, Alinovi R. et al . Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax. 2003; 58 (6) 505-509
81 Cap P, Pehal F, Petru V. et al . Leukotrienes in breath condensate in patients with asthma and COPD. Alergie. 2002; 1 15-20
82 Janssen L J. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol. 2001; 280 (6) L1067-1082
83 Baraldi E, Ghiro L, Piovan V. et al . Increased exhaled 8-isoprostane in childhood asthma. Chest. 2003; 124 (1) 25-31
84 Montuschi P, Collins J V, Ciabattoni G. et al . Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 2000; 162 (3 Pt 1) 1175-1177
85 Montuschi P, Ciabattoni G, Paredi P. et al . 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med. 1998; 158 (5 Pt 1) 1524-1527
86 Montuschi P, Kharitonov S A, Ciabattoni G. et al . Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax. 2000; 55 (3) 205-209 [Record as supplied by publisher]
87 Carpenter C T, Price P V, Christman B W. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest. 1998; 114 (6) 1653-1659
88 Carpagnano G E, Kharitonov S A, Resta O. et al . Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002; 122 (4) 1162-1167
89 Nowak D, Kalucka S, Bialasiewicz P. et al . Exhalation of H₂O₂ and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med. 2001; 30 (2) 178-186
90 Larstad M, Ljungkvist G, Olin A C. et al . Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 766 (1) 107-114
91 Mates M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 2000; 153 (1 - 3) 83-104
92 Hunt J F, Fang K, Malik R. et al . Endogenous airway acidification. Implications for asthma pathophysiology [see comments]. Am J Respir Crit Care Med. 2000; 161 (3 Pt 1) 694-699
93 Tate S, MacGregor G, Davis M. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax. 2002; 57 (11) 926-929
94 Vaughan J, Ngamtrakulpanit L, Pajewski T. et al . Exhaled breath condensate pH is a robust and reproducible assay of airway chemistry. Eur Respir J. 2003; in press
95 Hunt J F, Erwin E, Palmer L. et al . Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med. 2002; 165 (1) 101-107
96 Ho L P, Faccenda J, Innes J A. et al . Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J. 1999; 13 (1) 103-106
97 McRae K, De Perrot M, Fischer S. et al . Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation. J Heart Lung Transplant. 2001; 20 (2) 184
98 Carpagnano G E, Kharitonov S A, Wells A U. et al . Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease. Respiration. 2003; 70 (2) 154-160
99 Nayeri F, Millinger E, Nilsson I. et al . Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med. 2002; 96 (2) 115-119

Dr. Christian Gessner

Medizinische Klinik und Poliklinik I · Universitätsklinikum Leipzig

Johannisallee 32

04103 Leipzig

Email: gesc@medizin.uni-leipzig.de